Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mediven 95 class 2 (23-32mmHg) combined armsleeve with silicone top band
21270000220
|
Mediven 95 class 2 (23-32mmHg) combined armsleeve with silicone top band | Lymphoedema Garments | Appliances | No data available |
|
Mediven 95 class 2 (23-32mmHg) glove with compressive fingers
21270000245
|
Mediven 95 class 2 (23-32mmHg) glove with compressive fingers | Lymphoedema Garments | Appliances | No data available |
|
Mediven Mondi MTM class 1 (18-21mmHg) one-legged panty open toe
21270001889
|
Mediven Mondi MTM class 1 (18-21mmHg) one-legged panty open toe | Lymphoedema Garments | Appliances | No data available |
|
Mediven Plus class 3 (34-46mmHg) made to measure one-legged panty
21270002550
|
Mediven Plus class 3 (34-46mmHg) made to measure one-legged panty | Lymphoedema Garments | Appliances | No data available |
|
Medlance Plus lancets 1.5mm/25gauge
21010900876
|
Medlance Plus lancets 1.5mm/25gauge | Other Appliances | Appliances | No data available |
|
Medlance Plus lancets 2mm/0.8mm blade
21010900873
|
Medlance Plus lancets 2mm/0.8mm blade | Other Appliances | Appliances | No data available |
|
Medline Bordered Gauze dressing 10cm x 15cm
20030100707
|
Medline Bordered Gauze dressing 10cm x 15cm | Wound Management & Other Dressings | Dressings | No data available |
|
Medline Bordered Gauze dressing 10cm x 20cm
20030100708
|
Medline Bordered Gauze dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Medline Bordered Gauze dressing 10cm x 25cm
20030100709
|
Medline Bordered Gauze dressing 10cm x 25cm | Wound Management & Other Dressings | Dressings | No data available |
|
Medline Bordered Gauze dressing 5cm x 7cm
20030100704
|
Medline Bordered Gauze dressing 5cm x 7cm | Wound Management & Other Dressings | Dressings | No data available |
|
Medocodene 30mg/500mg capsules
0407010F0BRAAAD
|
Medocodene | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Medocodene 30mg/500mg effervescent tablets
0407010F0BRABAF
|
Medocodene | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Medox 50micrograms/ml / 5mg/ml eye drops
1106000ADBCAAAA
|
Medox | Latanoprost and timolol | Eye | No data available |
|
Medroxyprogesterone 100mg/5ml oral liquid
0803020H0AAANAN
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 10mg/5ml oral liquid
0803020H0AAARAR
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 200mg/5ml oral suspension
0803020H0AAAQAQ
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 20mg/5ml oral suspension
0803020H0AAAPAP
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 250mg tablets
0803020H0AAAEAE
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 400mg/5ml oral liquid
0803020H0AAAKAK
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 500mg tablets
0803020H0AAAGAG
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 500mg/2.5ml inj vials
0803020H0AAABAB
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Mefenamic acid 250mg/5ml oral suspension
1001010N0AAAGAG
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
|
Mefenamic acid 500mg/5ml oral suspension
1001010N0AAAHAH
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | No data available |
|
Mefoxin 1g powder for solution for injection vials
0501021E0BBAAAD
|
Mefoxin | Cefoxitin sodium | Infections | No data available |
|
Mefoxin 2g powder for solution for injection vials
0501021E0BBABAE
|
Mefoxin | Cefoxitin sodium | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.